January 8, 2020 / 7:50 PM / 2 months ago

Merck's Keytruda wins U.S. FDA approval for bladder cancer

Jan 8 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc's Keytruda for the treatment of a type of bladder cancer.

The therapy was approved for patients with a high-risk non-muscle invasive bladder cancer who are ineligible for or have opted out of surgical removal of part of the bladder. (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Aditya Soni)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below